Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
L Gaucher, Leslie Adda, Alice Séjourné, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Concomitant Statin Use and Survival in Patients With Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis
Yonghe Liao, Yuxuan Lin, Xinqi Ye, et al.
JCO Oncology Practice (2025)
Closed Access | Times Cited: 3
Global research trends on the links between the gut microbiome and cancer: a visualization analysis
Sa’ed H. Zyoud, Samah W. Al‐Jabi, Riad Amer, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47
Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
Sébastien Lopes, L. Pabst, Anne Dory, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors
Athéna Crespin, Clément Le Bescop, Jean de Gunzburg, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 23
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Yongchao Zhang, Hualei Chen, Shanshan Chen, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 53
The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
Jiaxin Zhou, Guowei Huang, Wan-Ching Wong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Proton Pump Inhibitors and Cancer: Current State of Play
Marie Bridoux, Nicolas Simon, Anthony Turpin
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Baoqing Chen, Yang Chen, Mihnea P. Dragomir, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 25
The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis
Yu‐Tzu Chang, Wan-Ying Lin, Yu-Cheng Chang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 284-284
Open Access | Times Cited: 24
Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Ziyang Mao, Xiaohui Jia, Panpan Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications
Julien Colard‐Thomas, Quentin Dominique Thomas, Marie Viala
Cancers (2023) Vol. 15, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 11
Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data
Soojung Hong, Ju Hyun Lee, Ja Yoon Heo, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 4
Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors
Jinhai Shen, Xinqi Ye, Hui Hou, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112243-112243
Closed Access | Times Cited: 4
The microbiome and the gut-lung axis in tuberculosis: interplay in the course of disease and treatment
Néstor Alvarado-Peña, David Galeana-Cadena, Itzel Alejandra Gómez-García, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study
Jiaxin Wang, Jie Lin, Huaijuan Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review
Massimiliano Cani, Paolo Bironzo, Ferdinando Garetto, et al.
Healthcare (2022) Vol. 11, Iss. 1, pp. 116-116
Open Access | Times Cited: 15
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors
Raffaele Giusti, Giampiero Porzio, Marco Maltoni, et al.
The Oncologist (2024)
Open Access | Times Cited: 3
The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Mingguang Ju, Ziming Gao, Xiao-Fang Liu, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2699-2708
Open Access | Times Cited: 14
Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
Brendan Sieber, Julius Strauss, Zihai Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
The impact of antibiotic use in gastrointestinal tumors treated with immune checkpoint inhibitors: systematic review and meta-analysis
Faizah Alotaibi, Ibrahim Abdullah S. Albalawi, Amna M. Anis, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Prognostic value of systemic immune-inflammation index/albumin ratio for immunotherapy-treated patients receiving opioids
Lei Yan, Pan Kang, Chengsong Cao, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0305119-e0305119
Open Access | Times Cited: 2
Opioid Use and Gut Dysbiosis in Cancer Pain Patients
Flaminia Coluzzi, Maria Sole Scerpa, Chiara Loffredo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7999-7999
Open Access | Times Cited: 2
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
Yoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, et al.
BJUI Compass (2021) Vol. 3, Iss. 2, pp. 154-161
Open Access | Times Cited: 15
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 842-842
Open Access | Times Cited: 11
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors
Yize Li, Hongmei Zhang
Current Opinion in Oncology (2021) Vol. 34, Iss. 1, pp. 95-106
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top